Literature DB >> 7910149

Immune complex p24 antigen: a new prognostic marker in human immunodeficiency virus infection.

T Cabezas1, E Quirós, F Garcia, J Hernández-Quero, M C Bernal, M A Martinez, J de la Higuera, G Piédrola, M C Maroto.   

Abstract

p24 antigen (p24 Ag) is usually not found in patients in the asymptomatic phase of HIV infection, mainly because it is bound to anti-p24 antibodies (p24 Ab), with which it forms immune complexes. Nine asymptomatic patients positive for HIV-1 antibodies (stage II CDC criteria) treated with r alpha-interferon were followed (7.5 +/- 0.5 months), and a basal and final sample were tested for p24 Ag immune complexes (p24 Ag-IC), free p24 Ag, p24 Ab, CD4 count, beta 2-microglobulin, properdin B factor, and C3 and C4 complement fractions. p24 Ag-IC was detected in 55.5% of the samples, whereas free p24 Ag was detected in 5.5%. The finding of no change or an increase in p24 Ag-IC serum levels may be considered a prognostic marker. We believe that p24 Ab cannot be used as a prognostic marker unless p24 Ag-IC detection is simultaneously evaluated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910149     DOI: 10.1007/bf01780756

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  HIV antigen detection in circulating immune complexes.

Authors:  L Kestens; G Hoofd; P L Gigase; R Deleys; G van der Groen
Journal:  J Virol Methods       Date:  1991-01       Impact factor: 2.014

Review 2.  Variation in HIV virus load of individuals at different stages in infection: possible relationship with risk of transmission.

Authors:  P Simmonds
Journal:  AIDS       Date:  1990       Impact factor: 4.177

Review 3.  Immunological and virological surrogate markers in the evaluation of therapies for HIV infection.

Authors:  F T Valentine; M A Jacobson
Journal:  AIDS       Date:  1990       Impact factor: 4.177

4.  Appearance of predictors of disease progression in relation to the development of AIDS.

Authors:  F de Wolf; J M Lange; J T Houweling; J W Mulder; J Beemster; P T Schellekens; R A Coutinho; J van der Noordaa; J Goudsmit
Journal:  AIDS       Date:  1989-09       Impact factor: 4.177

5.  Detection of infectious immune complexes in human immunodeficiency virus type 1 (HIV-1) infections: correlation with plasma viremia and CD4 cell counts.

Authors:  S A Fiscus; E B Wallmark; J D Folds; J Fryer; C M van der Horst
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

6.  Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus.

Authors:  W J Morrow; M Wharton; R B Stricker; J A Levy
Journal:  Clin Immunol Immunopathol       Date:  1986-09

7.  Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study.

Authors:  R A Kaslow; J P Phair; H B Friedman; D Lyter; R E Solomon; J Dudley; B F Polk; W Blackwelder
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

8.  Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.

Authors:  J Goudsmit; F de Wolf; D A Paul; L G Epstein; J M Lange; W J Krone; H Speelman; E C Wolters; J Van der Noordaa; J M Oleske
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

9.  A simple method for detecting HIV antibodies hidden in circulating immune complexes.

Authors:  E Ujhelyi; B Büki; V Salavecz; D Banhegyi; A Horvàth; G Füst; S R Hollàn
Journal:  AIDS       Date:  1987-09       Impact factor: 4.177

10.  Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection.

Authors:  J M Lange; D A Paul; F de Wolf; R A Coutinho; J Goudsmit
Journal:  AIDS       Date:  1987-05       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.